Recap: Masimo Q4 Earnings
Shares of Masimo (NASDAQ:MASI) fell in after-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share increased 7.69% year over year to $0.98, which beat the estimate of $0.86.
Revenue of $295,054,000 rose by 19.21% from the same period last year, which beat the estimate of $287,450,000.
Guidance
Masimo Sees FY21 Adj. EPS $3.80 vs $3.84 Est., Sales $1.2B vs $1.19B Est.
Details Of The Call
Date: Feb 23, 2021
Time: 04:30 PM
Technicals
52-week high: $284.86
Company's 52-week low was at $143.90
Price action over last quarter: Up 4.82%
Company Profile
Masimo is an Irvine, California-based medical device business that focuses on noninvasive patient monitoring. It began by developing superior signal processing algorithms to measure blood oxygenation levels through pulse oximetry and has expanded this expertise into a wide range of measurements and applications. The company generates revenue globally, with the United States the largest market (68% of 2019 sales), followed by Europe, the Middle East, and Africa (20%), Asia and Australia (9%), and North and South America excluding the U.S. (3%).
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
